Skip to content
Doseworth

Provider review

Pallas Health Review: "$199 a Month" Is Billed Every 12 Weeks

Pallas Health advertises compounded semaglutide at "$199/month" and tirzepatide at "$299/month". Neither is a monthly price. Both are a 12-week charge — $597 and $897 — divided by three, and 12 weeks is not three months. That cycle comes round 4.33 times a year, so semaglutide costs $2,587 rather than $2,388: one extra charge, arriving in a year the reader thought held twelve.

By Marla Whitfield, Pricing Editor

Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.

The money verdict

I would buy here, with the calendar corrected. Pallas does the two things almost nobody in this category does: it names all six pharmacies that fill its prescriptions and says outright that it owns none of them, and it names the treating group and the advising physician, both of which you can look up. Cancellation is free and self-serve. The pricing is not dishonest so much as badly divided — the per-cycle figure is exactly what the marketing implies, and it is the calendar underneath that costs you.

Worth it if

  • You can pay $597 in one go every 12 weeks rather than a smaller sum every month
  • You want every pharmacy that could fill your prescription named, and to be told plainly that Pallas owns none of them
  • You want to cancel yourself, for free, from your own account rather than by phone
  • You’re in one of the 43 states where the whole thing runs asynchronously, with no video visit to attend

Look elsewhere if

  • You want to try one cycle and stop — there is no month-to-month rung, so walking away still costs $597
  • You budgeted $2,388 for a year of semaglutide, because the 12-week cycle comes round more often than that and the year is $2,587
  • You’re in Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, West Virginia or Washington, D.C. and don’t want a live video visit and a $60 deposit
  • You want to use insurance, because none is accepted here at all
Cheapest — NAD+

$567/cycle

States served

All fifty states plus the District of Columbia, with 52 `/glp-1/<state>` paths published

Billing cycle

Every 12 weeks (4.33×/yr)

Pallas states that care is fully asynchronous in 43 states, and it names the exceptions rather than leaving them vague: Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota and West Virginia, plus Washington, D.C., all require a real-time video visit before a prescription is issued. In those, checkout collects a $60 visit deposit instead of the first payment and credits it against the first order.

At a glance

$567/cycle

Advertised

the standing rate

$567/cycle

Walk-away

same as advertised

$2,457

Year at this price

$567 × 4.33

What NAD+ costs

Pallas Health charges one rate: $567/cycle to start and the same after. It does not rise once the first cycle ends.

Ready to check Pallas Health’s current price?

Prices may change.

Best for: You can pay $597 in one go every 12 weeks rather than a smaller sum every month Skip it if: You want to try one cycle and stop — there is no month-to-month rung, so walking away still costs $597

Visit Pallas Health

What’s included

  • The compounded medication, shipped free, when it’s prescribed
  • The clinician review and ongoing check-ins, at one plan price rather than a separate consult fee
  • Care-team messaging and a self-serve portal at pallashealth.co/portal
  • A full refund if a clinician decides treatment isn’t right for you
  • Klarna pay-over-time at checkout, if you would rather spread the first charge

Pricing, per compound

Everything Pallas Health sells, cheapest year first. “Advertised” is the price it leads with; “Walk-away” is what you pay if you stop after one cycle.

ProviderAdvertisedWalk-awayYear at this price
NAD+ — nasal spray

Advertised as "$189/month", billed as $567 every 12 weeks, making the year $2,457 rather than the $2,268 implied. First month $79. This is the cheapest thing Pallas sells that a reader can actually buy.

$567.00/cycle$567.00/cycle$2,457.00

$567.00 × 4.33 twelve-week cycles

NAD+ — subcutaneous injection

Advertised as "$199/month", billed as $597 every 12 weeks — the same 12-week cycle as the GLP-1s, so the year is $2,587 rather than $2,388. First month $89. The nasal-spray form is cheaper at $567 every 12 weeks ("$189/month", $79 first month). Read at `/get-started/nad/productSelect`, which offers those two forms and no others.

$597.00/cycle$597.00/cycle$2,587.00

$597.00 × 4.33 twelve-week cycles

Semaglutide — compounded

Pallas advertises this as "$199/month". The charge is $597 every 12 weeks, and $597 ÷ 3 is $199 — so the per-cycle number is honest and the headline gap is zero. The unit isn’t: Pallas's own chunk stamps the renewal `renewalWeeks: 12` and then averages it with `Math.round(renewalCents/300)`, dividing 12 weeks by three months. A 12-week cycle arrives 52/12 = 4.33 times a year, so the year is $2,587 and not the $2,388 that "$199/mo" implies. The first four weeks are $139 as an intro rate, not the standing one, and renewals are anchored to 12 weeks starting four weeks after clinician approval. There’s no month-to-month rung for the compounded GLP-1s at all.

$597.00/cycle$597.00/cycle$2,587.00

$597.00 × 4.33 twelve-week cycles

Tirzepatide — compounded

Advertised as "$299/month", billed as $897 every 12 weeks. Same arithmetic as the semaglutide row and the same conclusion: $897 ÷ 3 = $299 is right per cycle, but 4.33 cycles a year makes the year $3,887 rather than $3,588. The first four weeks are $179 as an intro rate. Read at the medication-selection step of Pallas's own signup, where both molecules are shown side by side with separate prices — the selector doesn’t default you onto one.

$897.00/cycle$897.00/cycle$3,887.00

$897.00 × 4.33 twelve-week cycles

The year at this dose — 12 payments, or 13 where a seller bills every four weeks. Several charge more as you move to a higher dose; where they publish that, the row says so.

Every figure above was read on pallashealth.co, one product at a time. Check the current price before you buy.

See Pallas Health’s prices

How this compares

Pros and cons

Pros

  • Canceling is free and self-serve, effective at the end of the current billing period.
  • No FDA warning letter for Pallas, Brentmoor, or CareValidate.
  • It names all six pharmacies.
  • It names the clinical side too: Lion MD as the treating group, CareValidate as the clinical-operations platform, and Dr. Ana Lisa Carr, MD as advising physician.
  • The per-cycle price is exactly what the marketing implies.
  • LegitScript Healthcare Merchant certification, verified as issued rather than taken from the footer badge.
2 more
  • The molecule selector shows semaglutide and tirzepatide together with separate prices, so the signup flow asks which you want instead of defaulting you onto the dearer one.
  • All fifty states and D.C., with the asynchronous/video split published: 43 states are fully asynchronous, seven require a live video visit.

Cons

  • In the seven states requiring a video visit, checkout takes a $60 deposit.
  • Refunds of a qualifying payment are the amount paid minus processing costs and a $5 fee per refunded payment, for purchases from July 14, 2026 onward.
  • "$199/month" isn’t a monthly price, and the gap is one whole extra charge a year.
  • One of the six named pharmacies, Belmar, received an FDA warning letter in March 2023 over compounding quality.
  • There’s no month-to-month option for the compounded GLP-1s at any price.
  • The $139 and $179 opening rates are intro pricing for the first four weeks, not the standing rate, and the standing rate is roughly four times higher per cycle.
4 more
  • Pallas's own code carries a monthly/quarterly/6-month/12-month ladder for both molecules that the signup flow overrides and never offers — including a $269 semaglutide monthly rung. A price you can’t reach isn’t a price, but its presence in the codebase means the site is one config change from advertising rungs it doesn’t sell.
  • A third NAD+ product, a $99/month sublingual tablet with no intro discount, exists in the same chunk and is the only genuine month-to-month rung anywhere in the catalog. The live signup doesn’t offer it and there’s no route to it.
  • Brand-name drugs are cash-pay and dear: Zepbound $1,069, Ozempic $1,299, Wegovy $1,349 and Mounjaro $1,349 a month, when Lilly and Novo sell direct to self-pay patients for less.
  • No insurance is accepted at all; the whole business is cash-pay, though the site flags FSA/HSA eligibility.

Where else Pallas Health appears

Boards this company appears on

Compare the cost of compounded semaglutide · Compare the cost of compounded tirzepatide

How we verified this

What we checked

  • Every price read off pallashealth.co — 4 products, checked one at a time
  • The billing cycle taken from the company's own terms, not assumed from the price
  • States, inclusions and cancellation terms read on the company's own pages
  • Screened against the FDA's live warning-letter index

What to double-check before you buy

  • Prices may change. Confirm before you buy.

Key terms

Show definitions
Walk-away price
What one cycle costs at the ongoing rate with no commitment — what you actually pay if you stop after month one.
Year at this price
The walk-away price multiplied by however many times a year it's actually billed. It's the year at this dose only — several sellers charge more as you move up, and most don't publish the ladder.
Compounded
Made to order by a pharmacy from raw ingredients, rather than dispensed as an FDA-approved, mass-manufactured product.

Bottom line

Budget $597 every 12 weeks for semaglutide and $897 for tirzepatide — $2,587 and $3,887 a year, not $2,388 and $3,588. There is no month-to-month rung for either drug, so walking away after one cycle still costs $597, and the $139 and $179 opening rates cover the first four weeks only.

Visit Pallas Health

Frequently asked questions

What does Pallas Health actually cost per year?

$2,587 for compounded semaglutide and $3,887 for compounded tirzepatide, after the first four weeks. Those figures come from Pallas's own billing cadence: $597 and $897 charged every 12 weeks, and a 12-week cycle comes round 52/12 = 4.33 times in a year. The advertised "$199/month" and "$299/month" imply $2,388 and $3,588 — each about one charge short, because each treats 12 weeks as if it were three months.

Is the "$199 a month" figure dishonest?

Not about the money, and yes about the calendar. $597 divided by three genuinely is $199, and one 12-week block genuinely does contain about three months of medicine — so unlike most companies we track, Pallas isn’t hiding a fee or quoting a prepay rate it won’t honor. What it does is divide a 12-week charge by three months and print the result with a "/mo" on it. Twelve weeks is 84 days; three months is about 91. The seven-day difference is small until you multiply it across a year, at which point it’s an entire extra payment.

Can I pay Pallas monthly instead?

Not for the compounded GLP-1s or for NAD+. The signup flow offers a first month at an intro rate, and after that the only rung is the 12-week block. Pallas's code does contain a monthly ladder for both molecules, and a $99 month-to-month NAD+ tablet, but the live signup doesn’t offer any of them and there’s no page on the site that sells them.

Which pharmacy fills the prescription?

One of six that Pallas names publicly on its /clinical page: Belmar, Strive, The Pharmacy Hub, Foothills and two others, chosen by the medication, the patient's state and availability. Pallas states plainly that it doesn’t own or operate a pharmacy. Naming them at all puts Pallas ahead of most companies we track — and it means the one piece of history worth knowing is checkable: Belmar received an FDA warning letter in March 2023 about compounding quality, and the FDA closed that letter out in October 2023.

What happens if a clinician says no?

You’re refunded in full. That applies both to the plan price and to the $60 video-visit deposit charged in the seven states that require a synchronous visit. The exception Pallas states is abandonment: if you neither attend nor reschedule a required video visit and drop out of the intake, the deposit may be kept.

Sources

Every price above was checked against Pallas Health’s own pricing page — never a third-party aggregator:

Show every source link

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.